Calendar

Financial releases

Date Title  
Toggle Summary AbbVie to Present at the Jefferies 2017 Global Healthcare Conference
NORTH CHICAGO, Ill. , May 19, 2017 /PRNewswire/ --  AbbVie (NYSE: ABBV) will participate in the Jefferies 2017 Global Healthcare Conference on Thursday, June 8, 2017 . Bill Chase , executive vice president and chief financial officer, will present at 1:30 p.m. Central time .
Toggle Summary AbbVie to Present at the UBS Global Healthcare Conference
NORTH CHICAGO, Ill. , May 5, 2017 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the UBS Global Healthcare Conference on Monday, May 22, 2017 . Richard A. Gonzalez , chairman of the board and chief executive officer, will present at 7 a.m. Central time .
Toggle Summary AbbVie Reports First-Quarter 2017 Financial Results
- Reports First-Quarter Diluted EPS of $1.06 on a GAAP Basis; Adjusted Diluted EPS of $1.28, Reflecting Growth of 11.3 Percent - Delivers First-Quarter Net Revenues of $6.538 Billion on a GAAP Basis, Reflecting Growth of 10.1 Percent on an Operational Basis - First-Quarter Global Humira Sales of
Toggle Summary AbbVie to Present at the Deutsche Bank 42nd Annual Health Care Conference
NORTH CHICAGO, Ill. , April 21, 2017 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Deutsche Bank 42 nd Annual Health Care Conference on Wednesday, May 3, 2017 . William Chase , executive vice president and chief financial officer, will present at 7:40 a.m. Central time .
Toggle Summary AbbVie to Host First-Quarter Earnings Conference Call
NORTH CHICAGO, Ill. , April 6, 2017 /PRNewswire/ --  AbbVie (NYSE: ABBV) will announce its first-quarter 2017 financial results on Thursday, April 27, 2017 , before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time ( 9 a.m. Eastern).
Toggle Summary AbbVie to Present at the Barclays Global Healthcare Conference
NORTH CHICAGO, Ill. , March 1, 2017 /PRNewswire/ --  AbbVie (NYSE: ABBV) will participate in the Barclays Global Healthcare Conference on Wednesday, March 15, 2017 . William Chase , executive vice president and chief financial officer, will present at 8 a.m. Central time .
Toggle Summary AbbVie Announces $5 Billion Increase to Stock Repurchase Program
NORTH CHICAGO, Ill. , Feb. 17, 2017 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) has authorized a $5 billion increase to AbbVie's existing stock repurchase program. Purchases may be made from time to time in management's discretion.
Toggle Summary AbbVie Declares Quarterly Dividend
NORTH CHICAGO, Ill. , Feb. 16, 2017 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) declared a quarterly cash dividend of $0.64 per share.  The cash dividend is payable May 15, 2017 to stockholders of record at the close of business on April 13, 2017 .
Toggle Summary AbbVie to Present at the Cowen and Company 37th Annual Health Care Conference
NORTH CHICAGO, Ill. , Feb. 15, 2017 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Cowen and Company 37th Annual Health Care Conference on Wednesday, March 8, 2017 . William Chase , executive vice president and chief financial officer, will present at 8:20 a.m. Central time .
Toggle Summary AbbVie Reports Full-Year and Fourth-Quarter 2016 Financial Results
- Reports Full-Year Diluted EPS of $3.63 on a GAAP Basis; Adjusted Diluted EPS of $4.82, Reflecting Growth of 12.4 Percent - Delivers Full-Year Net Revenues of $25.638 Billion on a GAAP Basis; Adjusted Net Revenues of $25.560 Billion Grew 13.3 Percent on an Operational Basis - Full-Year Global